Evidence map›Paper›PMID 33843933›Full record

ArticleJournal of visualized experiments : JoVE2021

Production of Membrane-Filtered Phase-Shift Decafluorobutane Nanodroplets from Preformed Microbubbles.

Darrah A Merillat, Arvin Honari, Shashank R Sirsi

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Darrah A MerillatDepartment of Bioengineering, The University of Texas at Dallas.
Arvin HonariDepartment of Bioengineering, The University of Texas at Dallas.
Shashank R SirsiDepartment of Bioengineering, The University of Texas at Dallas; Department of Radiology, The University of Texas Southwestern; Shashank.Sirsi@utdallas.edu.
The University of Texas at Dallas · USThe University of Texas Southwestern Medical Center · US

Funding

Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma TherapyR01CA235756 · NCI · UNIVERSITY OF TEXAS DALLAS · PI HERNANDEZ, SONIA LORENA, SIRSI, SHASHANK RAMESH · 2019 to 2023
$2.0M
NCI NIH HHS R01 CA235756
6 · The paper itself

Abstract

There are many methods that can be used for the production of vaporizable phase-shift droplets for imaging and therapy. Each method utilizes different techniques and varies in price, materials, and purpose. Many of these fabrication methods result in polydisperse populations with non-uniform activation thresholds. Additionally, controlling the droplet sizes typically requires stable perfluorocarbon liquids with high activation thresholds that are not practical in vivo. Producing uniform droplet sizes using low-boiling point gases would be beneficial for in vivo imaging and therapy experiments. This article describes a simple and economical method for the formation of size-filtered lipid-stabilized phase-shift nanodroplets with low-boiling point decafluorobutane (DFB). A common method of generating lipid microbubbles is described, in addition to a novel method of condensing them with high-pressure extrusion in a single step. This method is designed to save time, maximize efficiency, and generate larger volumes of microbubble and nanodroplet solutions for a wide variety of applications using common laboratory equipment found in many biological laboratories.

Indexed as

FluorocarbonsMicrobubblesNanotechnologyFluorocarbonsperfluorobutane

Identifiers

PMID33843933
PMCPMC8820680
OpenAlexW3136542748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.